<DOC>
	<DOCNO>NCT02700425</DOCNO>
	<brief_summary>The goal study compare effectiveness pace physiologic His bundle ( HB ) lead position versus standard coronary sinus ( CS ) lead position subject heart failure undergo cardiac resynchronization therapy ( CRT ) . While placement leave ventricular lead via coronary sinus anatomic limitation , hypothesis achievement QRS narrow His bundle capture superior improve systolic function echocardiographic index ( ejection fraction strain ) quality life decrease rehospitalization mortality .</brief_summary>
	<brief_title>His Bundle Pacing Versus Coronary Sinus Pacing Cardiac Resynchronization Therapy</brief_title>
	<detailed_description>This randomize , single-blinded study 40 patient strategy HB pace versus CS pacing , remain blinded treatment allocation . Both treatment option use standard-of-care , FDA-approved device . The distinction allocation toward HB pace CS pacing . Treating physician aware assignment order facilitate routine device follow-up . Echocardiographic electrocardiographic evaluation also perform blinded manner . Cross-over permit treatment group allocation : - CS lead place due difficult cannulation CS , limited branch posterolateral lateral wall , phrenic nerve capture . These subject may cross-over HB pacing . - HB pace subject may cross-over HB lead position adequate stability reasonable pacing output , QRS width narrow least 20 % QRS width ≤ 130 msec . Implant procedure per routine percutaneous access , standard pacemaker ICDs . All subject receive FDA-approved cardiac resynchronization therapy pacemaker defibrillator device , per standard care outline subject . In order facilitate optimal lead placement , arterial access levo-phase CS angiography and/or LV septal mapping characterize site bundle-branch block may also perform , discretion implant physician per his/her standard practice . Follow-up perform 2 week post-implant incision check device interrogation standard care . In addition , routine device clinical follow-up schedule 1 , 3 , 6 , 12 month . Electrocardiography ( ECG ) perform pre-implant , prior hospital discharge , 3 month , 6 month , 12 month . Echocardiography perform pre-implant 6 month evaluate change LVEF , chamber dimension , wall motion strain image standard care treatment patient advance heart failure . NYHA functional class quality life ( utilizing Kansas City Cardiomyopathy Questionnaire ) assess pre-implant 6 month .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients least 18 year age LV systolic dysfunction LVEF ≤ 35 % Evidence intraventricular conduction delay QRS duration &gt; 120 msec NYHA Class II , III , ambulatory Class IV heart failure either ischemic nonischemic cardiomyopathy patient NYHA Class I symptoms ischemic cardiomyopathy Left ventricular ejection fraction ( LVEF ) ≤ 35 % , sinus rhythm ( SR ) , leave bundlebranch block ( LBBB ) morphology , QRS duration ≥ 150 msec , NYHA Class II , III , ambulatory Class IV patient goaldirected medical therapy ( GDMT ) [ Class I ] LVEF ≤ 35 % , SR LBBB QRS 120149 msec GDMT [ Class IIa ] LVEF ≤ 35 % , SR nonLBBB QRS ≥ 150 msec GDMT [ Class IIa ] LVEF ≤ 35 % , AF medication AV nodal ablation allow near 100 % pace [ Class IIa ] LVEF ≤ 35 % undergoing new replacement device anticipate &gt; 40 % ventricular pacing GDMT [ Class IIa ] LVEF ≤ 30 % , ischemic etiology HF , SR LBBB ≥ 150 msec NYHA Class I symptoms GDMT [ Class IIb ] LVEF ≤ 35 % , SR nonLBBB QRS 120149 msec , NYHA Class III/ambulatory Class IV HF GDMT [ Class IIb ] LVEF ≤ 35 % , SR nonLBBB QRS ≥ 150 msec , NYHA Class II HF GDMT [ Class IIb ] Existing CRT device Inability patient capacity provide consent either due medical psychiatric comorbidity Pregnancy Participation trial Difficulty followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Wide QRS</keyword>
	<keyword>Ventricular Dyssynchrony</keyword>
</DOC>